Epoetin receptor status may alter the outcomes in head and neck cancers treated with radiotherapy and darbepoetin-alpha

dc.contributor.authorTopkan, Erkan
dc.contributor.authorYildirim, Berna Akkus
dc.contributor.orcID0000-0001-8120-7123en_US
dc.contributor.pubmedID30414758en_US
dc.contributor.researcherIDAAG-2213-2021en_US
dc.date.accessioned2021-02-28T16:43:16Z
dc.date.available2021-02-28T16:43:16Z
dc.date.issued2019
dc.identifier.endpage190en_US
dc.identifier.issn0167-8140en_US
dc.identifier.scopus2-s2.0-85053661520en_US
dc.identifier.startpage190en_US
dc.identifier.urihttp://hdl.handle.net/11727/5457
dc.identifier.volume130en_US
dc.identifier.wos000456709600027en_US
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.radonc.2018.07.010en_US
dc.relation.journalRADIOTHERAPY AND ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectERYTHROPOIETIN RECEPTORen_US
dc.subjectEXPRESSIONen_US
dc.subjectCELLSen_US
dc.titleEpoetin receptor status may alter the outcomes in head and neck cancers treated with radiotherapy and darbepoetin-alphaen_US
dc.typeletteren_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: